Published in Gut on June 01, 1996
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest (1998) 3.18
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr (2009) 1.90
The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia (2010) 1.67
The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol (2013) 1.67
GLP-1 and energy balance: an integrated model of short-term and long-term control. Nat Rev Endocrinol (2011) 1.62
A dose-response strategy reveals differences between normal-weight and obese men in their metabolic and inflammatory responses to a high-fat meal. J Nutr (2014) 1.45
Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care (2011) 1.17
Acute effect of walking on energy intake in overweight/obese women. Appetite (2010) 1.05
Obesity may attenuate the HbA1c-lowering effect of sitagliptin in Japanese type 2 diabetic patients. J Diabetes Investig (2012) 0.99
Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci (1998) 0.92
The effect of Korean pine nut oil (PinnoThin) on food intake, feeding behaviour and appetite: a double-blind placebo-controlled trial. Lipids Health Dis (2008) 0.92
Gastric stimulation for weight loss. World J Gastroenterol (2012) 0.91
Differential secretion of satiety hormones with progression of obesity in JCR:LA-corpulent rats. Obesity (Silver Spring) (2008) 0.87
A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior. Physiol Behav (2014) 0.87
Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovasc Diabetol (2013) 0.87
Prior exercise and postprandial incretin responses in lean and obese individuals. Med Sci Sports Exerc (2013) 0.87
The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review. Dig Dis Sci (2007) 0.84
Clinical characteristics of the responders to dipeptidyl peptidase-4 inhibitors in Korean subjects with type 2 diabetes. J Korean Med Sci (2013) 0.83
Circulating ghrelin and GLP-1 are not affected by habitual diet. Regul Pept (2012) 0.82
Specific appetite, energetic and metabolomics responses to fat overfeeding in resistant-to-bodyweight-gain constitutional thinness. Nutr Diabetes (2014) 0.81
Obesity-associated biomarkers and executive function in children. Pediatr Res (2014) 0.81
Postprandial effects of polydextrose on satiety hormone responses and subjective feelings of appetite in obese participants. Nutr J (2015) 0.80
Childhood obesity: a role for gut microbiota? Int J Environ Res Public Health (2014) 0.79
Metabolic effects of an entero-omentectomy in mildly obese type 2 diabetes mellitus patients after three years. Clinics (Sao Paulo) (2011) 0.79
The effect of family-based multidisciplinary cognitive behavioral treatment in children with obesity: study protocol for a randomized controlled trial. Trials (2011) 0.79
Peripheral signals mediate the beneficial effects of gastric surgery in obesity. Gastroenterol Res Pract (2015) 0.78
Reducing dietary fat from a meal increases the bioavailability of exogenous carbohydrate without altering plasma glucose concentration. J Appl Physiol (1985) (2008) 0.77
Nutrient-specific feeding and endocrine effects of jejunal infusions in obese animals. Am J Physiol Regul Integr Comp Physiol (2014) 0.77
Glucagon-like peptide-1 regulation of carbohydrate intake is differentially affected by obesogenic diets. Obesity (Silver Spring) (2011) 0.77
Ability of GLP-1 to decrease food intake is dependent on nutritional status. Physiol Behav (2014) 0.77
Emerging role of GLP-1 receptor agonists in the treatment of obesity. Diabetes Metab Syndr Obes (2010) 0.76
Potential use of exenatide for the treatment of obesity. Expert Opin Investig Drugs (2011) 0.76
Stomachs: does the size matter? Aspects of intestinal satiety, gastric satiety, hunger and gluttony. Clinics (Sao Paulo) (2012) 0.75
Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr (2016) 0.75
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity. World J Diabetes (2016) 0.75
Failure of sucrose replacement with the non-nutritive sweetener erythritol to alter GLP-1 or PYY release or test meal size in lean or obese people. Appetite (2016) 0.75
Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight. Am J Physiol Gastrointest Liver Physiol (2015) 0.75
Metabolic and Hormonal Alterations with Diacylglycerol and Low Glycemic Index Starch during Canine Weight Loss. ISRN Vet Sci (2012) 0.75
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet (1963) 16.71
Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med (1992) 4.37
NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE. Lancet (1964) 3.41
Exon duplication and divergence in the human preproglucagon gene. Nature (1983) 2.37
Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol (1993) 2.12
Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett (1987) 1.86
Plasma free fatty acid turnover rate in obesity. Acta Med Scand (1969) 1.43
Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes (1993) 1.30
Radioimmunoassay of gastric inhibitory polypeptide. Ann Clin Biochem (1978) 1.00
Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet Med (1993) 0.94
The enteroinsular axis revisited. A novel role for an incretin. N Engl J Med (1992) 0.89
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
Clinical biochemistry nearer the patient. Br Med J (Clin Res Ed) (1983) 2.63
The WHO programme for the evaluation and testing of new insecticides. Bull World Health Organ (1971) 2.53
Mitochondrial DNA analyses and the origin and relative age of parthenogenetic lizards (genus Cnemidophorus). Science (1979) 2.48
Glucose tolerance and diabetes in chronic liver disease. Lancet (1967) 2.33
Stimulation of glucagon secretion by oral glucose. Lancet (1965) 2.30
Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol (1993) 2.12
Length variation and heteroplasmy are frequent in mitochondrial DNA from parthenogenetic and bisexual lizards (genus Cnemidophorus). Genetics (1985) 2.07
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab (2001) 1.97
Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf) (1990) 1.91
Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH) Clin Endocrinol (Oxf) (1998) 1.90
Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child (1990) 1.86
Blood and urine gold levels during chrysotherapy for rheumatoid arthritis. Rheumatol Rehabil (1975) 1.79
Physiological changes underlying jet lag. Br Med J (Clin Res Ed) (1982) 1.76
Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr (2003) 1.75
Radioimmunoassay of cannabinoids in blood and urine. Lancet (1974) 1.73
A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals. Diabetes Metab Res Rev (2010) 1.71
Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone. Br Med J (1979) 1.66
Enhancement of glucose-stimulated insulin release by an intestinal polypeptide in rats. Lancet (1972) 1.59
A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method. Br J Clin Pharmacol (1976) 1.58
Immunochemical glucagon in human pancreas, gut, and plasma. Lancet (1966) 1.55
Alleviation of jet lag by melatonin: preliminary results of controlled double blind trial. Br Med J (Clin Res Ed) (1986) 1.53
The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas. J Clin Invest (1988) 1.48
Lunchtime gin and tonic a cause of reactive hypoglycaemia. Lancet (1977) 1.48
Endocrinological and metabolic effects of alcohol. Proc R Soc Med (1977) 1.47
Can melatonin alleviate jet lag? Br Med J (Clin Res Ed) (1983) 1.46
No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man. Br J Nutr (1999) 1.45
effect on performance of reducing blood-alcohol with oral fructose. Lancet (1967) 1.44
Osteoporosis in treated adult coeliac disease. Gut (1995) 1.43
Station and cervical dilation at epidural placement in predicting cesarean risk. Obstet Gynecol (1999) 1.42
Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab (1985) 1.41
Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats. Brain Res (1996) 1.39
Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia (2003) 1.37
Postprandial hormone and metabolic responses amongst shift workers in Antarctica. J Endocrinol (2001) 1.37
Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon. Diabetes (1966) 1.35
Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis (1981) 1.35
The development of a radioimmunoassay for cannabinoids in blood and urine. J Pharm Pharmacol (1975) 1.30
Value of plasma-lithium monitoring. Lancet (1971) 1.29
Hypothalamic-pituitary function following successful treatment of intracranial tumours. Clin Endocrinol (Oxf) (1976) 1.28
Tissue gold levels after chrysotherapy. Ann Rheum Dis (1974) 1.25
Hepatic dysfunction in heroin and cocaine users. Br J Addict Alcohol Other Drugs (1967) 1.23
Hypoglycaemia. 2. Other causes. Clin Endocrinol Metab (1976) 1.20
Chromosome polymorphism and banding patterns in the owl monkey (Aotus). Lab Anim Sci (1976) 1.20
Prednisolone levels in the plasma and urine: a study of two preparations in man. Br J Clin Pharmacol (1975) 1.19
Prednisolone absorption in acute colitis. Gut (1980) 1.19
Symptomatic hypercalcaemia in thyrotoxicosis. Br Med J (1970) 1.16
Carcinoma of stomach and other non-pancreatic lesions as causes of spontaneous hypoglycaemia. Br J Surg (1965) 1.13
The treatment of hypoglycaemia with diazoxide. Proc R Soc Med (1966) 1.12
Alcohol-induced pseudo-Cushing's syndrome. Lancet (1977) 1.12
Effects of renal function on plasma digoxin levels in elderly ambulant patients in domiciliary practice. Br Med J (1972) 1.12
Some effects of melatonin and the control of its secretion in humans. Ciba Found Symp (1985) 1.12
Postprandial hormone and metabolic responses in simulated shift work. J Endocrinol (1996) 1.11
Development of a radioimmunoassay for etorphine (preliminary communication). Res Commun Chem Pathol Pharmacol (1975) 1.10
Immunohistochemical studies of the GABA system in the pancreas. Neuroendocrinology (1983) 1.10
A rapid micro-method for determining four anti-convulsant drugs by gas-liquid chromatography. Clin Chim Acta (1973) 1.08
The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. Br J Clin Pharmacol (1986) 1.08
Plasma levels of ionised calcium and magnesium in thyroid disease. Lancet (1967) 1.08
Morbidity and mortality from heroin dependence. 3. Relation of hepatitis to self-injection techniques. Br Med J (1968) 1.07
Amphetamine taking among young offenders. Br J Psychiatry (1969) 1.07
Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability. Br J Clin Pharmacol (1978) 1.07
Plasma and myocardial digoxin concentrations in patients on oral therapy. Br Heart J (1969) 1.07
Methods for the preparation of enzyme-antibody conjugates for use in enzyme immunoassay. Methods Enzymol (1981) 1.07
The role of clinical biochemistry in community health. R Soc Health J (1972) 1.06
Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein-3. Ann Clin Biochem (1992) 1.05
Monocyte esterase deficiency in malignant neoplasia. J Clin Pathol (1990) 1.05
Changing concepts of vector control in malaria eradication. Annu Rev Entomol (1972) 1.05
Comparison of two methods of preparing enzyme-antibody conjugates: application of these conjugates for enzyme immunoassay. Anal Biochem (1979) 1.04
Proceedings: Development of a radioimmunoassay for morphine having minimal cross-reactivity with codeine. J Endocrinol (1975) 1.04
Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept (1992) 1.03
A fatal motor-car accident and cannabis use. Investigation by radioimmunoassay. Lancet (1976) 1.03
High dose intravenous methylprednisolone "pulse" therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function. Eur J Clin Pharmacol (1982) 1.02
Streptozotocin treatment of malignant islet cell tumour. Br Med J (1970) 1.00
Intestinal factors in the regulation of insulin secretion. Adv Metab Disord (1970) 1.00
The effects of alcohol, barbiturate, and diazepam on hypothalamic-pituitary-adrenal function in chronic alcoholics. Lancet (1972) 1.00
Radioimmunoassay of gastric inhibitory polypeptide. Ann Clin Biochem (1978) 1.00
Plasma-hydrocortisone response to ethanol in chronic alcoholics. Lancet (1969) 1.00
Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol (1991) 0.99
Health without wealth? Costa Rica's health system under economic crisis. J Public Health Policy (1987) 0.99
Inadvertent intake of sulphonylurea. Ann Clin Biochem (1990) 0.99
Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon. Clin Endocrinol (Oxf) (1995) 0.99
Diurnal variation in prednisolone kinetics. Clin Pharmacol Ther (1983) 0.98
Enzyme immunoassay: a review. Ann Clin Biochem (1979) 0.98
The anterograde and retrograde infusion of glucagon antibodies suggests that A cells are vascularly perfused before D cells within the rat islet. Diabetologia (1989) 0.98
Determination of the urinary metabolites of caffeine and theophylline by high-performance liquid chromatography. A comparative study of a direct injection and an ion-pair extraction procedure. J Chromatogr (1986) 0.97
Radioimmunoassay and saturation analysis. Pharmacology. Br Med Bull (1974) 0.97
Second survey of insecticid-resistance in body-lice, 1958-63. Bull World Health Organ (1965) 0.96
Pancreatic somatostatinoma presenting with hypoglycaemia. Clin Endocrinol (Oxf) (1980) 0.96
ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol (2000) 0.96
Acoustic and vestibular defects in lightning survivors. Laryngoscope (1974) 0.95
Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. Diabet Med (1998) 0.94
Spot indole test: evaluation of four reagents. J Clin Microbiol (1982) 0.94
24-hour profiles of melatonin, cortisol, insulin, C-peptide and GIP following a meal and subsequent fasting. Clin Endocrinol (Oxf) (1982) 0.93
Measurement of therapeutic agents in blood. Adv Clin Chem (1973) 0.93
Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci Rep (1986) 0.93
Hypoglycaemia of non-endocrine origin (non-islet cell tumours). Proc R Soc Med (1966) 0.93
The laser Doppler: a non-invasive measure of cochlear blood flow. Acta Otolaryngol (1985) 0.93